Inventor · disambiguated record
Deyao Li
Also filed as: LI DEYAO
7 granted patents·3 pending applications·0 citations·filing 2016–2023
67Inventor score
Files withGUANGZHOU HENOVCOM BIOSCIENCE CO LTD7DANA FARBER CANCER INST INC2CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD1
Top patents by PatentIndex Score
10 records- 0158US12060385B2Compounds for RNA capping and uses thereofGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2023·Granted Aug 13, 2024·0 cites·29 claims
- 0251US12497378B2Tetrahydronaphthalene compounds, pharmaceutical compositions, and uses thereofGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2021·Granted Dec 16, 2025·0 cites·20 claims
- 0349US11369583B2Long-acting prodrugs of rasagiline, preparing methods and uses thereofGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2018·Granted Jun 28, 2022·0 cites·8 claims
- 0449US2022227700A1Hdac3 catalytic inhibitor development and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0546US12496348B2Small molecule target bromo/acetyl proteins and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Granted Dec 16, 2025·0 cites·25 claims
- 0646US10919856B2Cyclohexene compounds and use thereofGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2017·Granted Feb 16, 2021·0 cites·6 claims
- 0745US11236094B2Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitorsCSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·20 claims
- 0844US11292811B2Long-acting prodrugs of entecavir, preparing methods and uses thereofGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2018·Granted Apr 5, 2022·0 cites·7 claims
- 0941US2019167593A1Cyclohexene derivative or pharmaceutically acceptable salt thereof, and application of sameGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2017·Application pending·0 cites
- 1037US2018303810A1Nimodipine Water-Soluble Derivative, And Preparation Method And Use ThereofGUANGZHOU HENOVCOM BIOSCIENCE CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Deyao Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →